[APLS] YoY Quarter Result on 30-Jun-2017 [#Q2]

Stock
[APLS] Apellis Pharmaceuticals, Inc.
Announcement Date
29-Jun-2017
Financial Year
2017
Quarter
30-Jun-2017 [#Q2]
Profit Trend
QoQ- -33.97%
YoY- -82.43%
Quarter Report
APLS's Result
APLS's Financial Summary
View:
Show?
Quarter Result
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -118,617 -71,090 -33,334 -12,126 -6,647 -3,969 -2,843 86.12%
Tax 6,914 388 -33,669 -12,138 38 413 28 150.26%
NP -118,617 -71,090 -33,334 -12,126 -6,647 -3,555 -2,815 86.43%
Tax Rate - - - - - - - -
Total Cost 118,617 71,090 33,334 12,126 6,647 3,555 2,815 86.43%
Ratio Analysis
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
EPS -1.57 -1.12 -0.61 -0.67 -0.79 -0.78 -0.61 17.04%
EPS Diluted -1.57 -1.12 -0.61 -0.67 -0.79 -0.78 -0.61 17.04%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.